In the present study, we describe the results of the intradermal hypersensitivity test to assess a possible IgE-mediated HSR in patients that received intravenous rituximab in the context of B-cell lymphoma following a 12-step desensitization protocol. The gene discussed is IGHE; the disease is B-cell non-Hodgkin lymphoma.